StockData
Bright Minds Biosciences Inc. logo

Bright Minds Biosciences Inc. (DRUG) stock

DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 23, 2025Score 5/30
$20.76+0.25 (+1.22%)

Close on Nov 18, 2026Market cap $158.52MP/E –Yield –

Bright Minds Biosciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -C$8.69M. The highest annual figure on record is -C$288.39K in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-C$8.69M–
FY2024Sep 30, 2024-C$1.85M–
FY2023Sep 30, 2023-C$7.02M–
FY2022Sep 30, 2022-C$13.59M–
FY2021Sep 30, 2021-C$7.32M–
FY2020Sep 30, 2020-C$288.39K–

More Bright Minds Biosciences figures

See a number that looks wrong?